INTRAVASCULAR IMAGING SOLVE MY CASE: MOST CHALLENGING CASES BY EXPERTS PART II

Sunday, March 9, 2025

9:57 AM – 11:28 AM ET

Moderator(s)

Farouc A. Jaffer, MD, PhD

Director Coronary Intervention and CTO PCI Program
Massachusetts General Hospital / Harvard Medical School
Boston, Massachusetts, United States

Disclosure(s): Intravascular Imaging, Durvena, Fastwave: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); Massachusetts General Hospital: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing), Royalty - Canon, Terumo, Spectrawave from IP held by MGH (Ongoing); Shockwave, Novartis, Magenta Medical, Medtronic, Cleerly, Genomadix: Consulting Fees (e.g., advisory boards) (Ongoing); Siemens, Canon, Neovasc/Shockwave, Teleflex, Boston Scientific, Amarin, Heartflow, OrbusNeich: Grant/Research Support (Ongoing)
Jasvindar Singh, MD

Professor of Medicine, Director, Interventional Cardiology, Medical Director, Cardiac Catheterization Laboratory
Washington University School of Medicine/ Barnes Jewish Hospital
St Louis, Missouri, United States

Disclosure(s): Abbott Vascular, Medtronic, Boston Scientific: Consultant (Ongoing); Biotronik: Consultant (Ongoing); Penumbra, Inc.: Consultant (Ongoing); Philips-Volcano: Consultant (Ongoing); Shockwave Medical: Consultant (Ongoing)

Panel Discussant(s)

Ali Denktas, MD, FACC

Professor of Medicine/ Director, Cardiac Catheterization Laboratories
Baylor College of Medicine
Houston, Texas, United States

Disclosure(s): No financial relationships to disclose

Disclosure(s):

Farouc A. Jaffer, MD, PhD: Intravascular Imaging, Durvena, Fastwave: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); Massachusetts General Hospital: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing), Royalty - Canon, Terumo, Spectrawave from IP held by MGH (Ongoing); Shockwave, Novartis, Magenta Medical, Medtronic, Cleerly, Genomadix: Consulting Fees (e.g., advisory boards) (Ongoing); Siemens, Canon, Neovasc/Shockwave, Teleflex, Boston Scientific, Amarin, Heartflow, OrbusNeich: Grant/Research Support (Ongoing)

Jasvindar Singh, MD: Abbott Vascular, Medtronic, Boston Scientific: Consultant (Ongoing); Biotronik: Consultant (Ongoing); Penumbra, Inc.: Consultant (Ongoing); Philips-Volcano: Consultant (Ongoing); Shockwave Medical: Consultant (Ongoing)

Ali Denktas, MD, FACC: No financial relationships to disclose

Eric A. Osborn, MD, PhD: Abiomed: Consultant (Ongoing); Dyad Medical: Grant/Research Support (Ongoing), Scientific Advisory Board (Ongoing), Stock-privately held company (Ongoing); Gentuity: Consultant (Ongoing); NuPulse CV, Inc.: Consultant (Ongoing), Grant/Research Support (Ongoing); Opsens: Consultant (Ongoing), Grant/Research Support (Ongoing); Philips: Consultant (Ongoing), Grant/Research Support (Ongoing)